ASMB - Assembly Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5332.81M
Enterprise Value 3152.5M
Trailing P/E N/A
Forward P/E 1-2.45
PEG Ratio (5 yr expected) 1-0.18
Price/Sales (ttm)22.01
Price/Book (mrq)1.74
Enterprise Value/Revenue 310.08
Enterprise Value/EBITDA 6-1.53

Trading Information

Stock Price History

Beta (3Y Monthly) 0.65
52-Week Change 3-68.36%
S&P500 52-Week Change 36.70%
52 Week High 344.65
52 Week Low 312.75
50-Day Moving Average 314.06
200-Day Moving Average 317.96

Share Statistics

Avg Vol (3 month) 3258.13k
Avg Vol (10 day) 3225.09k
Shares Outstanding 520.43M
Float 21.23M
% Held by Insiders 112.14%
% Held by Institutions 185.99%
Shares Short (Jun 28, 2019) 4894.32k
Short Ratio (Jun 28, 2019) 43.3
Short % of Float (Jun 28, 2019) 43.66%
Short % of Shares Outstanding (Jun 28, 2019) 43.49%
Shares Short (prior month May 31, 2019) 41.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Jul 14, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-661.85%

Management Effectiveness

Return on Assets (ttm)-30.13%
Return on Equity (ttm)-69.37%

Income Statement

Revenue (ttm)15.12M
Revenue Per Share (ttm)0.63
Quarterly Revenue Growth (yoy)9.00%
Gross Profit (ttm)-57.94M
EBITDA -99.49M
Net Income Avi to Common (ttm)-101.55M
Diluted EPS (ttm)-4.20
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)193.54M
Total Cash Per Share (mrq)7.56
Total Debt (mrq)13.22M
Total Debt/Equity (mrq)6.95
Current Ratio (mrq)7.97
Book Value Per Share (mrq)7.45

Cash Flow Statement

Operating Cash Flow (ttm)-73.4M
Levered Free Cash Flow (ttm)-25.64M